SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-23-000025
Filing Date
2023-08-10
Accepted
2023-08-10 07:00:51
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q howl-20230630.htm   iXBRL 10-Q 1341455
2 EX-31.1 a06302023ex311.htm EX-31.1 9537
3 EX-31.2 a06302023ex312.htm EX-31.2 9558
4 EX-32.1 a06302023ex321.htm EX-32.1 7072
  Complete submission text file 0001785530-23-000025.txt   5259377

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20230630.xsd EX-101.SCH 34128
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT howl-20230630_cal.xml EX-101.CAL 46007
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT howl-20230630_def.xml EX-101.DEF 185154
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20230630_lab.xml EX-101.LAB 438834
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20230630_pre.xml EX-101.PRE 317459
57 EXTRACTED XBRL INSTANCE DOCUMENT howl-20230630_htm.xml XML 527319
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 231157127
SIC: 2834 Pharmaceutical Preparations